Abemaciclib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-or$iented and realizes industrial development through R✘&D innovation and technology transformation.

key word:

Pharmaceutical innovative

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large he♠alth industry finance platform company integrating pharmaceutical, intelligent medical, bio 'pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing pr​oducts include Foucault reaction, nitration reaction, sulfonation reaction, •hydrogenation reaction, fluorination reaction, chlorination reaction, brominat<ion reaction, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DλPP4) inhibitor developed by Merck. In October 2006‍, Sitagliptin phosphate Januvia was approved by FDA as the first DPP4 inhibitor for ≈the treatment of type ⅱ diabetes mellitus. The characteristics of this drug are th∞at it can stimulate insulin secretion while reducing hunger without causing weight gain. Hypoglycem↔ia and edema will not occur, and it is suitable for diabetic patients with p←oor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orien ted and realizes industrial development through R&D innovation and technology transformation✔.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important p↕roducts for the treatment of arthritis. It is well tolerate♣d and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major l≠eukotriene receptor antagonists. In clinical application, it has good therapeutic effect on a<topic asthma and other types of bronchial asthma, and the market prospect ∑is huge. In the major category of asthma drugs, leukotriene recepto♣r antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterp rise that is market-oriented and realizes industrial development ☆through R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug app™roved by FDA for Alzheimer's disease in the United States. Its treatment reaches ×the target dose and has low toxic and side effects. It has been widely recognized by ouλr medical community, and good tolerance is its biggest advantage. In October 199φ9, Donepezil was launched in China under the trade name "Aricept", which is the main chemical drug ♥against Alzheimer's disease. At present, CFDA has approved a number of do☆mestic enterprises to produce donepezil preparations, th€e main dosage forms are tablets, capsules, dispersive δtablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Squibb/≤Pfizer), a direct oral factor Xa inhibitor, was approveσd for use in the 27 EU member states. The world's first drug approved toπ prevent venous thromboembolism (VTE) in adult patients un↕dergoing elective hip or knee replacement. From June 2019 to June 2020, the annual sa↑les of apixaban products overseas reached about $15.4 billion, with a year-on-πyear growth of nearly 32%, and the API consumption reached ÷about 23,960 kg, with a year-on-year growth of about 28%". Compared with its main competitor, Rivaroxaban, the drug's annua•l overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-o<riented and realizes industrial development through≤ R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On Decemb✔er 29, 2004, it was approved by FDA for the treatment of reγfractory or relapsed acute lymphoblastic leukemia (ALL) in childre"n.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical en<terprise that is market-oriented and realizes induπstrial development through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other ser☆vices, E-mail: 2880705932@qq.com